A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

Condition:   Prostate Adenocarcinoma Intervention:   Drug: Niraparib Pill Sponsor:   Abramson Cancer Center of the University of Pennsylvania Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials